Why Patients Choose Cannabis
Areas of therapeutic interest
Patients turn to medicinal cannabis for a wide range of conditions. Tap any area below to learn what patients commonly report and what the research says.
A 1:1 THC:CBD ratio addresses pain while CBD moderates psychoactivity. Myrcene and caryophyllene add anti-inflammatory support. Tinctures allow precise dose titration; topical balm for localized joint or muscle pain.
- THCEngages CB1 receptors along pain-processing pathways; patients commonly report reduced pain intensity.
- CBDNon-intoxicating; interacts with TRPV1 and inflammatory signaling, and can moderate THC’s psychoactivity.
- CBGEarly research explores CB2-linked anti-inflammatory activity.
CBD, CBG, and CBC all target CB2 receptors without psychoactivity. Caryophyllene is the only terpene that directly activates CB2, making it the primary terpene choice here. Topical cream for localized inflammation; tincture or gummies for systemic conditions.
- CBDThe most-studied cannabinoid for inflammation-related signaling, including cytokine modulation.
- CBGResearch explores immune-cell CB2 interactions and inflammatory response.
- THCAThe raw, non-intoxicating acid form of THC, studied for anti-inflammatory potential.
CBN is the cannabinoid most associated with sedation. A low-dose THC addition can deepen sleep onset. Myrcene and linalool are the signature sleep terpenes. Gummies taken 60 minutes before bed, or tincture 30 minutes prior for faster onset.
- CBNA mildly sedating oxidation product of THC; the cannabinoid most associated with nighttime formulations.
- THCCommonly reported to shorten time to fall asleep; dose strongly influences sleep quality.
- CBDHigher doses are commonly reported as calming, while low doses can be alerting.
THCV acts as a CB1 antagonist at lower doses, which can help suppress anxiety-driven responses without sedation. CBD-dominant with linalool and limonene creates a calming-yet-clear profile. Tincture allows quick dose adjustment; beverage format suits daytime use.
- CBDInteracts with serotonin 5-HT1A receptors; the most-studied cannabinoid for calm without intoxication.
- THCBiphasic: low doses are commonly reported as relaxing, while larger doses can heighten anxiety.
- CBGEarly patient reports explore mood and stress support.
CBDA is a potent 5-HT1A agonist, the same receptor targeted by prescription anti-nausea medication, and may be more bioavailable than CBD for this use. THC adds appetite support. Tincture or beverage for faster onset, avoiding the stomach disruption of oral capsules when nausea is active.
- THCActs on CB1 receptors in brainstem regions tied to nausea; prescription THC analogs exist for this use.
- CBDResearch explores serotonin-linked anti-nausea pathways.
- CBGEarly research explores appetite support.
CBDV is in active clinical trials for Rett syndrome and ASD. Pinene may support cognitive clarity and partially offset THC-related memory effects. Neurological conditions vary significantly; ThrivePath recommends physician-guided formulation with consistent dosing tracked over 4-8 weeks.
- CBDA purified CBD medicine is FDA-approved for certain rare seizure disorders.
- THCStudied for muscle spasticity, notably in multiple sclerosis, where relief is commonly reported.
- CBCEarly laboratory research explores neuroprotective signaling.
Quality-of-life goals benefit from a balanced, adaptable formulation. A daytime-oriented terpene blend with limonene and pinene supports mood and clarity; switching to linalool and myrcene in the evening supports relaxation and sleep. ThrivePath consultants help patients dial in the right morning and evening split.
- THC:CBDGentle balanced ratios are commonly chosen for overall comfort, mood, and daily function.
- CBGOften called the mother cannabinoid; early research spans mood, comfort, and focus.
- THCVAmong the minor cannabinoids under active study for targeted effects.
Tincture is strongly preferred here - precise dropper dosing is essential when substituting for a pharmaceutical with a known dose. Tapering should always be done under physician supervision. ThrivePath can work with your care team to document formulation, dosing schedule, and response tracking.
- CBDAffects liver CYP450 enzymes that process many common medications; physician guidance is essential.
- THC:CBDPatients commonly report reducing reliance on other medications under medical supervision, never on their own.
We start with your condition, sensitivity, lifestyle, and goals. We match a cannabinoid ratio, terpene profile, and delivery format to that picture. After a 2-4 week trial, we review and refine. The goal is a formulation that fits your life, not a generic recommendation.
Individual results vary. These statements have not been evaluated by the FDA. Cannabis is not intended to diagnose, treat, cure, or prevent any disease. Always consult a licensed physician about your condition and whether medicinal cannabis is appropriate for you.